about
A review of MRI findings in schizophreniaCiticoline in addictive disorders: a review of the literatureA critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorderStructure of aspartoacylase, the brain enzyme impaired in Canavan diseaseLocalisation of N-acetylaspartate in oligodendrocytes/myelinClinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain.NAA-weighted imaging of the human brain using a conventional readout gradient.MRI anatomy of schizophrenia.Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.Proton magnetic resonance spectroscopy of the human brain in schizophrenia.Magnetic resonance spectroscopy and its applications in psychiatry.A Review of Magnetic Resonance Spectroscopy Studies in Marijuana using Adolescents and Adults.Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Deconstructing psychosis with human brain imaging.Magnetic resonance imaging and temporal lobe epilepsy.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or isoflurane.Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy.Region-specific effects on brain metabolites of hypoxia and hyperoxia overlaid on cerebral ischemia in young and old rats: a quantitative proton magnetic resonance spectroscopy study.Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolismEarly detection of secondary damage in ipsilateral thalamus after acute infarction at unilateral corona radiata by diffusion tensor imaging and magnetic resonance spectroscopy.Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.Central nervous system involvement in diabetic neuropathy.Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.Neuroplasticity and cellular resilience in mood disorders.Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study.Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy studyLong-term follow-up after gene therapy for canavan disease.The underlying neurobiology of bipolar disorderPKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.Cell pathology in bipolar disorder.
P2860
Q24657354-C6FC40F4-A1EE-4E49-BC7C-36CD0F4A3A56Q27014895-A9BB0FDE-5B70-4368-B937-FB587E651300Q27025872-D8C3BFFD-70BB-45CD-A280-D11A38CDE12AQ27640995-ABA65A11-7470-4353-841B-B9825B7341AFQ28304873-9F38FBE9-8725-454A-AC05-6C81B15D19F2Q30471723-EE50870B-E690-482E-9EF2-BED88836B3D0Q30558437-BD7A8FB8-BB40-4FF7-B633-F1C80175ECF4Q30577334-9C9D574E-F64F-4F20-84D1-2A542EA76BEAQ30585268-991666B6-E197-4D17-A64D-03715C5D3F55Q30587234-DBC683AE-A4BC-4258-9243-093BBDB937F4Q30684591-3B60B0EB-6DAC-4A67-B76E-DAFB07E107D3Q30768975-382EB74A-C725-450A-90A4-2A7EFB2EF335Q30981655-BA9F1452-92D9-4601-9642-48BF5A7B1334Q30983010-453A4DB4-0D92-4F7B-99F5-B14998B2F20FQ30996805-4D6D7A5B-13B7-45ED-AA8F-0471DD3CD757Q31114592-E22EE9D3-9F73-4723-B682-A0FD6ED3C03BQ31978728-6C5B2787-9AA7-481F-8721-D46CA4C4CBAFQ32115381-8DF5B8FD-0F00-4DB5-A96D-AE54DE852DB4Q33179619-8826A160-F376-4E14-9429-DEAFCE6C10F5Q33206291-A8B5A5B8-32B9-4AB3-BE6F-438930289382Q33271816-3A54DC0E-AC41-4C0E-9968-32ABF2053474Q33334499-B8566310-6ED7-4FCD-97EB-38758C9156BFQ33411020-D9878EC5-EEDC-4D6E-9B15-F4FA03B282DFQ33612276-B8DBFD6D-16E1-42FD-A071-C2EC5490722DQ33685438-B89EC8A9-778A-4E32-AC89-AFF96AAD1FDEQ33728535-9CA89E49-0397-4A1E-ABF7-778C0A1B84F8Q33738391-48260FC1-FE2E-4712-ADC3-5AD449C89DC1Q33890045-72995055-E2D9-42F1-9B9F-D07C31C85EBAQ33908187-133317CD-292B-49AF-8144-B5DD89E306E5Q33930708-927BFC6C-2A1A-41D9-A909-669CE131700AQ33933163-88CAD27E-17D4-49C2-AF76-CC2917B28CD7Q33971691-60B60C4C-8B57-4412-82CB-A9FFB3A7AD2AQ34111006-1A17450B-2475-4A38-BF80-61C26401794AQ34133170-98503459-0B0F-45E7-87AF-816866D67F84Q34155813-A4204AE5-5FB4-42BB-AF70-C9DD47A30E61Q34238730-96940482-A439-45F5-B456-AEA700AA7D26Q34318553-BAE00988-FD26-4709-A5A5-E9D0457E21E0Q34562614-28DDE9C5-0F94-47BA-B99E-66A0E83878DEQ34622380-F096F8FF-F681-4163-9DDF-446AF7B7EC49Q34692741-B81D23C7-46B1-4900-9503-DF8BF95EFE21
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
N-acetylaspartate in neuropsychiatric disorders.
@en
type
label
N-acetylaspartate in neuropsychiatric disorders.
@en
prefLabel
N-acetylaspartate in neuropsychiatric disorders.
@en
P1476
N-acetylaspartate in neuropsychiatric disorders.
@en
P304
P356
10.1016/0301-0082(95)00014-M
P577
1995-08-01T00:00:00Z